PRESS RELEASE published on 08/11/2026 at 15:21, 1 month ago Form 8.3 - The Vanguard Group, Inc.: Gamma Communications plc The Vanguard Group, Inc. discloses a 1.39% interest in Gamma Communications plc. Purchase of 1,110 securities at 9.73 GBP per unit on 10 August 2026 Investment Stock Purchase Vanguard Group Financial Disclosure Gamma Communications PLC
PRESS RELEASE published on 08/11/2026 at 15:21, 1 month ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc The Vanguard Group, Inc. discloses a 2.71% interest in Schroders plc on 10 August 2026 under Rule 8.3 of the Takeover Code The Vanguard Group, Inc. Disclosure Rule 8.3 Schroders Plc Interests
PRESS RELEASE published on 08/11/2026 at 15:20, 1 month ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc The Vanguard Group, Inc. discloses a 4.76% position in Tate & Lyle plc. Form 8.3 filed in compliance with Takeover Code Form 8.3 Position Disclosure Takeover Code Vanguard Group Tate & Lyle Plc
PRESS RELEASE published on 08/11/2026 at 15:19, 1 month ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses 3.55% stake in Spire Healthcare Group plc as of 10 August 2026 The Vanguard Group Financial Disclosure Stake Disclosure Investment Disclosure Spire Healthcare Group Plc
PRESS RELEASE published on 08/11/2026 at 15:17, 1 month ago Form 8.3 - The Vanguard Group, Inc.: SEGRO plc The Vanguard Group discloses 5.65% ownership in SEGRO plc. Disclosure under Rule 8.3 of the Takeover Code. Prologis, Inc. also involved Disclosure Rule 8.3 Vanguard Group SEGRO PLC Prologis Inc.
PRESS RELEASE published on 08/11/2026 at 15:17, 1 month ago Form 8.3 - The Vanguard Group, Inc.: Bodycote plc The Vanguard Group, Inc. discloses holding 5.43% stake in Bodycote plc as of August 10, 2026. Details of open positions in relevant securities provided in Form 8.3 Form 8.3 Relevant Securities The Vanguard Group Stake Disclosure Bodycote PLC
BRIEF published on 08/10/2026 at 15:51, 1 month 1 day ago The Vanguard Group's Position on Tate & Lyle plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group Tate & Lyle
BRIEF published on 08/10/2026 at 15:49, 1 month 1 day ago The Vanguard Group Discloses Position in Spire Healthcare Group Form 8.3 Takeover Code Vanguard Group Spire Healthcare Shareholding
BRIEF published on 08/10/2026 at 15:47, 1 month 1 day ago The Vanguard Group Reveals Position in SEGRO plc Disclosure Takeover Code Vanguard Group Stock Positions SEGRO PLC
BRIEF published on 08/10/2026 at 15:46, 1 month 1 day ago The Vanguard Group, Inc. Discloses Position in Schroders plc Form 8.3 Takeover Code Schroders Plc Vanguard Group Shareholding Disclosure
Published on 09/11/2026 at 23:00, 14 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 1 hour 9 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 1 hour 49 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 6 hours 14 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 15:25, 7 hours 49 minutes ago Revolve Signs Agreement to Acquire 9.6 MW Operating Wind Project in the US and Secures Project-Level Debt Financing with EDC and Vancity
Published on 09/11/2026 at 22:15, 59 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 hour 4 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 3 hours 29 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 4 hours 59 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 16 hours 14 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 16 hours 14 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 1 day 3 hours ago Availability of the 2026 Interim Financial Report
